Company: SYRA
Filing Date: 2025-03-11
Form Type: 10-K
Source: 0001493152-25-009873
Chunk: 278

Company: Syra Health Corp
Filing Date: 2025-03-11
Form: 10-K
Item: Item 1A
Chunk 278
---
 been brought against companies following a decline in the market price of their securities.
This risk is especially relevant for us because healthcare companies have experienced significant share price volatility in recent years.
If we face such litigation, it could result in substantial costs and a diversion of management’s attention and resources, which
could harm our business.

-23-

Anti-takeover
provisions contained in our Certificate of Incorporation and our Amended and Restated Bylaws (“Bylaws”), as well as provisions
of Delaware law, could impair a takeover attempt.

Our
Certificate of Incorporation, Bylaws and Delaware law contain provisions which could have the effect of rendering more difficult, delaying
or preventing an acquisition deemed undesirable by our board of directors. Our corporate governance documents include or will include
provisions:

    ●
    authorizing
    “blank check” preferred stock, which could be issued by our board of directors without stockholder approval and may contain
    voting, liquidation, dividend, and other rights superior to our Class A common stock;

    ●
    limiting
    the liability of, and providing indemnification to, our directors and officers;

    ●
    limiting
    the ability of our stockholders to call and bring business before special meetings;

    ●
    requiring
    advance notice of stockholder proposals for business to be conducted at meetings of our stockholders and for nominations of candidates
    for election to our board of directors;

    ●
    controlling
    the procedures for the conduct and scheduling of board of directors and stockholder meetings; and

    ●
    providing
    our board of directors with the express power to postpone previously scheduled annual meetings and to cancel previously scheduled
    special meetings.

These
provisions, alone or together, could delay or prevent hostile takeovers and changes in control or changes in our management.

As
a Delaware corporation, we are also subject to provisions of Delaware law, including Section 203 of the Delaware General Corporation
law, which prevents some stockholders holding more than 15% of our outstanding common stock from engaging in certain business combinations
without approval of the holders of substantially all of our outstanding common stock.

Any
provision of our Certificate of Incorporation, Bylaws or Delaware law that has the effect of delaying or deterring a change in control
could limit the opportunity for our stockholders to receive a premium for their shares of our Class A common stock and could also affect
the price that some investors are willing to pay for our Class A common stock.